362 Followers on Owler

ADC Therapeutics

is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers... Read more
OverviewCompetitorsFundingNews & Insights

ADC Therapeutics

is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers... Read more
ADC Therapeutics President & CEO: Ameet Mallik

President & CEO

Ameet Mallik

CEO Approval Rating

86/100

2011

PublicNYSEADCT

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$79.2M
Employees
193
Funding
$1.4B

News

Conference Presentation
Oct 27, 2025
Benzinga
ADC Therapeutics to Present at November Investor Conferences
Funding
Oct 13, 2025
PR Newswire
ADC Therapeutics received $60M in PIPE Funding

ADC Therapeutics Competitors

1AbbVie
2Daiichi Sankyo
3Genmab
4CytomX
5BioAtla
6ImmunoGen
7Astellas
8Pfizer
9Genentech
10Mersana Therapeutics
Unlock 13 + competitors

Trending Companies